Abstract
The Convention on Biological Diversity (CBD) is a major international agreement to ensure the conservation of biological diversity, the sustainable use of various components of biological diversity, and fair and equitable access and benefit sharing of advances arising from the use of related genetic resources. The CBD excludes human genetic resources. In light of the rapid advances in biotechnology, genetic resources are increasingly being utilised by different types of users and in different industries. This usage is not confined to plants, animals or micro-organisms but includes human genetic resources and sometimes a mix of such resources. In the absence of any international agreement, various national governments are framing their own rules and guidelines. This patchwork of regulation may eventually impede global research efforts. This chapter argues that the CBD is qualified to be the central agency at the global level for the advance of broader benefit sharing frameworks. By implication, the scope of the CBD should be expanded to include human genetic resources.
| Original language | English |
|---|---|
| Title of host publication | Benefit Sharing |
| Subtitle of host publication | From Biodiversity to Human Genetics |
| Publisher | Springer Netherlands |
| Pages | 153-177 |
| Number of pages | 25 |
| ISBN (Electronic) | 9789400762053 |
| ISBN (Print) | 9400762046, 9789400762046 |
| DOIs | |
| State | Published - 1 Dec 2012 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Access and benefit sharing
- Biomedical technology
- Convention on Biological Diversity
- Developing countries
- Human genetic resources
- World Health Organization
Fingerprint
Dive into the research topics of 'Promoting an inclusive approach to benefit sharing: Expanding the scope of the CBD?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver